scispace - formally typeset
Open AccessJournal ArticleDOI

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.

Reads0
Chats0
TLDR
The clearance time and factors influencing 2019 novel coronavirus (2019-nCoV) RNA in different samples from patients with COVID-19 were analyzed, providing further evidence to improve the management of patients during convalescence and showed that the CD4+ T lymphocyte count may help predict the duration of viral RNA detection in patients’ stools.
Abstract
Background: A patient's infectivity is determined by the presence of the virus in different body fluids, secretions, and excreta. The persistence and clearance of viral RNA from different specimens of patients with 2019 novel coronavirus disease (COVID-19) remain unclear. This study analyzed the clearance time and factors influencing 2019 novel coronavirus (2019-nCoV) RNA in different samples from patients with COVID-19, providing further evidence to improve the management of patients during convalescence.

read more

Citations
More filters
Journal ArticleDOI

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.

TL;DR: A systematic review and meta-analysis of published gastrointestinal symptoms and detection of virus in stool, and a analysis of data from a cohort of patients with COVID-19 in Hong Kong found that 17.6% of patientsWith CO VID-19 had gastrointestinal symptoms, and healthcare workers should exercise caution in collecting fecal samples or performing endoscopic procedures in patients with CoV-2—even during patient recovery.
Journal ArticleDOI

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.

TL;DR: The large proportion of asymptomatic children indicates the difficulty in identifying paediatric patients who do not have clear epidemiological information, leading to a dangerous situation in community-acquired infections.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI

First Case of 2019 Novel Coronavirus in the United States.

TL;DR: This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
Journal ArticleDOI

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

TL;DR: The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians as little data is available that describe the disease pathogenesis, and no pharmacological therapies of proven efficacy yet exist, so understanding the evidence for harm or benefit from corticosteroids in 2019-n coV is of immediate clinical importance.
Related Papers (5)
Trending Questions (2)
Does Covid 19 affect RNA?

Because of the delayed clearance of viral RNA in the glucocorticoid treatment group, glucocorticoids are not recommended in the treatment of COVID-19, especially for mild disease.

Does Covid effect RNA?

This study analyzed the clearance time and factors influencing 2019 novel coronavirus (2019-nCoV) RNA in different samples from patients with COVID-19, providing further evidence to improve the management of patients during convalescence.